Comparison of engraftment following different stem cell mobilization modalities in patients with multiple myeloma treated with a uniform induction regimen containing bortezomib, cyclophosphamide and dexamethasone
Crossref DOI link: https://doi.org/10.1007/s00277-016-2897-2
Published Online: 2016-12-24
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Benyamini, Noam
Avivi, Irit
Dann, Eldad J.
Zuckerman, Tsila
Lavi, Noa
Katz, Tami
License valid from 2016-12-24